The US Food and Drug Administration on Friday approved Novartis AG?s combination therapy to treat an aggressive type of thyroid cancer.The therapy, which uses Novartis? Tafinlar and Mekinist, was approved to treat anaplastic thyroid cancer that...
You are posting as a guest.
If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.
.thumb.png.ea12d62fcb43a79b1d7a7a4664107cbc.png)
The US Food and Drug Administration on Friday approved Novartis AG?s combination therapy to treat an aggressive type of thyroid cancer.The therapy, which uses Novartis? Tafinlar and Mekinist, was approved to treat anaplastic thyroid cancer that...
0 Comments
Recommended Comments
There are no comments to display.
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.